Last reviewed · How we verify

Proflavine Hemisulfate — Competitive Intelligence Brief

Proflavine Hemisulfate (Proflavine Hemisulfate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Acridine dye; DNA intercalating agent. Area: Oncology.

marketed Acridine dye; DNA intercalating agent DNA (non-specific intercalation) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Proflavine Hemisulfate (Proflavine Hemisulfate) — M.D. Anderson Cancer Center. Proflavine hemisulfate is an acridine dye that intercalates into DNA and generates reactive oxygen species, causing direct antimicrobial and antiproliferative effects.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Proflavine Hemisulfate TARGET Proflavine Hemisulfate M.D. Anderson Cancer Center marketed Acridine dye; DNA intercalating agent DNA (non-specific intercalation)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Acridine dye; DNA intercalating agent class)

  1. M.D. Anderson Cancer Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Proflavine Hemisulfate — Competitive Intelligence Brief. https://druglandscape.com/ci/proflavine-hemisulfate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: